Merck Joins Princeton Catalysis Initiative

By C. Todd Reichart
Monday, February 11 2019

February 11, 2019. The Princeton Catalysis Initiative (PCI) continues to build its community of industrial and academic partnerships. This month Merck, known as MSD outside the United States and Canada, joined the initiative with a 10-year funding commitment, creating opportunities for Merck and Princeton researchers to work more closely together.

“Merck is honored to join the Princeton Catalysis Initiative,” said Mike Kress, Senior Vice President Process Research and Development, Merck Research Laboratories. “We look forward to strengthening collaborations between industry and academia across a broad range of scientific disciplines.” 

Rebecca Kohnz, Senior Scientist at Merck Research Laboratories, in conversation with Daniel Cohen, Assistant Professor of Mechanical & Aerospace Engineering, during a break at the 2nd Annual Princeton Catalysis Initiative symposium, held over January 15-16, 2019.
Rebecca Kohnz, Senior Scientist at Merck Research Laboratories, in conversation with Daniel Cohen, Assistant Professor of Mechanical & Aerospace Engineering, during a break at the 2nd Annual Princeton Catalysis Initiative symposium, held over January 15-16, 2019.
Photo by C. Todd Reichart

Researchers from Merck were among those invited to attend the 2nd Annual Princeton Catalysis Initiative symposium, held over January 15-16, 2019, and featuring over 40 short presentations by Princeton faculty from eight departments across campus. 

“The PCI offers a unique opportunity to expand our productive collaboration with Princeton beyond synthetic chemistry,” said Emma Parmee, Vice President Discovery Chemistry, Merck Research Laboratories.

Speaking of Merck’s longstanding relationship with Princeton, David MacMillan, the James S. McDonnell Distinguished University Professor of Chemistry and one of the PCI founders said, “Over the last 15 years, Merck has been exceptional in supporting research activities at Princeton University. Its involvement in PCI will provide a new mechanism for Princeton and Merck scientists to work together to enable societal benefit.”